Friday, June 28, 2013

Dendreon's Provenge Recommended by European committee

New article posted at Seeking Alpha:

Dendreon Gets European Recommendation

See also my: Q1 2013 Dendreon Analyst Conference Notes

Provenge is approved in the United States for the treatment of metastatic minimally symptomatic castrate-resistant prostate cancer. Dendreon is seeking approval for Provenge in Europe.

No comments:

Post a Comment